Home » Topics » Regulatory

Regulatory
RSS

U.S. launch of Risperdal Consta

Dec. 9, 2003

Zorbtive receives FDA approval for short bowel syndrome

Dec. 5, 2003

Sepracor reports phase III program results for Xopenex HFA MDI

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

Gadovist 1.0 receives E.U. approval for MRA

Dec. 2, 2003

Nebido receives approval in Finland

Dec. 1, 2003

Mutual recognition procedure completed for high-dose Symbicort Turbuhaler

Dec. 1, 2003

Plenaxis receives FDA approval

Nov. 28, 2003

Allergan submits NDA for oral tazarotene for psoriasis

Nov. 27, 2003

Climara Pro receives FDA approval

Nov. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...